Digital Health Buzz!

HomeAuthorDigital Health Buzz!, Author at

Digital Health Buzz! aims to be the destination of choice when it comes to what’s happening in the digital health world. We are not about news and views, but informative articles and thoughts to apply in your business.
https://digitalhealthbuzz.com/wp-content/uploads/2019/02/3.jpeg

Eight recent health IT vendor contracts and go-lives: 1. Veterans across the U.S. will soon have the option to access their medical data through the iPhone’s Health app, thanks to a new partnership between Apple and the U.S. Department of Veterans Affairs. 2. Rochester, Minn.-based Mayo Clinic and technology company Leidos entered into a strategic collaboration to advance the research, development and market adoption of tools and technologies for patient care. 3. MIB, a membership...

https://digitalhealthbuzz.com/wp-content/uploads/2019/02/HIMSS2019_Joe-Harpaz-2.jpeg

HIMSS19 show floor. Modernizing Medicine. Every February, approximately 40,000 health IT professionals from across the country gather at the Healthcare Information and Management Systems Society (HIMSS) conference to discuss the future of healthcare and the new tech innovations in the pipeline. Like the Consumer Electronics Show (CES) for the tech world, HIMSS sets the stage for the coming year in health IT, showcasing new innovations and setting the themes that will define the months to...

https://digitalhealthbuzz.com/wp-content/uploads/2019/02/AR-190219501.jpeg

Hide caption A name that graces world-renowned museums and programs at elite universities is rapidly becoming synonymous with the opioid crisis, as the owners of OxyContin manufacturer Purdue Pharma and its Coventry, R.I. subsidiary are named in a series of lawsuits. The Sackler name is on world-renowned museums and elite-university programs. But except for their philanthropy, the Sacklers have mostly remained private. That may soon change. Sackler family members own multibillion-dollar OxyContin manufacturer Purdue Pharma...

https://digitalhealthbuzz.com/wp-content/uploads/2019/02/twp-social-share.jpeg

Pharma and its drug-pricing practices have come under fire from critics on the right and left, and from lawmakers on Capitol Hill to Donald Trump’s White House. But amid the political bashing, here’s something that may come as a surprise: The industry managed to save taxpayers some money. That conclusion comes out of a recent study in Health Affairs from Harvard economist and Obamacare architect David Cutler, which sought to identify the reasons behind a...

https://digitalhealthbuzz.com/wp-content/uploads/2019/02/sponcon3.0.jpeg

Louise Roe has denim that’s ripped in all the right places, a bikini-ready body year-round, a husband and baby who look like they were picked from a catalog, and 698,000 Instagram followers. She also has the skin condition psoriasis, a chronic autoimmune disease defined by flaky, inflamed red or white patches of skin, and she wants you to know all about it. Actually, she needs to tell you about her psoriasis on Instagram; otherwise, her...

https://digitalhealthbuzz.com/wp-content/uploads/2019/02/FSD_LOGO_Stack.jpeg

TORONTO–( BUSINESS WIRE )–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD”), a licensed producer under the Cannabis Act, today provided a corporate update on operations, strategy and leadership changes. Management Changes On February 6, 2019, the Company announced it had implemented changes in leadership and business practices to optimize operations. Accordingly, the Company announced that Dr. Raza Bokhari, Executive Co-Chairman, has been appointed interim Chief Executive Officer of FSD Pharma. “It is with...

https://digitalhealthbuzz.com/wp-content/uploads/2019/02/1541785049-1708.jpeg

Insys Therapeutics Inc. founder John Kapoor was so determined to get back the millions he spent launching the company that he led Insys on a disastrous path of pushing its addictive opioid drug on patients who didn’t need them, his former chief executive officer testified. The way Kapoor ignored his subordinates, “you really don’t want to push back because once he makes up his mind, the decision is done,” Michael Babich told a Boston jury...

https://digitalhealthbuzz.com/wp-content/uploads/2019/02/15.02.19-605x340-1.jpeg

Sanofi has become the latest big pharma firm to appoint a chief digital officer, choosing Ameet Nathwani to take up the position, adding onto his current role of executive vice president, chief medical officer. In the newly-created role, Dr Nathwani will be responsible for enhancing Sanofi’s strategy to integrate digital technologies and medical science to improve patient outcomes. Ameet Nathwani His mandate will include scaling up Sanofi’s ongoing portfolio of digital initiatives by developing broad...

https://digitalhealthbuzz.com/wp-content/uploads/2019/02/index.jpeg

Kitov Pharma Ltd (NASDAQ:KTOV) and Cerecor Inc. (NASDAQ:CERC) are two firms in the Biotechnology that compete against each other. Below is a comparison of their risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Kitov Pharma Ltd 1.00M 22.61 5.20M -0.98 0.00 Cerecor Inc. 15.58M 13.32 41.68M -1.05 0.00 Table 1 shows gross revenue, earnings per share (EPS) and valuation...

https://digitalhealthbuzz.com/wp-content/uploads/2019/02/idou0i8npiela31ml1e4.png

Screenshot: Insys Theraputics/U.S. Attorney’s Office That drug companies have fueled the opioid crisis by flooding the market with deceptively marketed, highly addictive painkillers is no secret. But the antics of Insys Therapeutics, now being revealed in an ongoing federal court battle, seem especially evil. Well, evil and incredibly, supremely ridiculous. On Wednesday, the AP reported , it emerged in court that Insys employees produced a rap video to motivate sale reps to keep pushing an...

Hey there!

Sign in

Forgot password?
Close
of

    Processing files…